A short summary of long COVID: Looking back and peeking forward

+Practice

In print

OCCUPATIONAL HEALTH

A short summary of long COVID: Looking back and peeking forward

26 October 2022

David McBride

Wednesday 26 October 2022, 12:30 AM

Horseshoe bats are the natural reservoir of SARS-CoV-2 [Image: Nils Bouillard on Unsplash]

Occupational health expert David McBride looks at what we know about the origins of the pandemic, the clinical profile of long COVID, and how we might manage the problem

Key points, Patients with long COVID can experience multiple symptoms in every area of the body. Multidisciplinary, clinically experienced teams will be needed , Pract Green w Pale Yellow

COVID-19

References

Pekar JE, Magee A, Parker E, et al. The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2. Science 2022;377(6609):960–66.
Qui, J. How China’s ‘Bat Woman’ Hunted Down Viruses from SARS to the New Coronavirus. Scientific American, 1 June 2020.
Standaert M, Dou E. In search for coronavirus origins, Hubei caves and wildlife farms draw new scrutiny. The Washington Post, 11 October 2021.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506.
de Melo GD, Lazarini F, Levallois S, et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med 2021;13(596):eabf8396.
Liu YH, Chen Y, Wang QH, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study. JAMA Neurol 2022;79(5):509–17.
Castanares-Zapatero D, Chalon P, Kohn L, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 2022;54(1):1473–87.
Rayner C, Campbell R. Long Covid implications for the workplace. Occup Med (Lond) 2021;71(3):121–23.
Kavi, L. PoTS on a Page – GP Guide. PoTS UK, 2023. https://www.potsuk.org/pots-for-medics/gp-guide/
Hippisley-Cox J, Young D, Coupland C, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart 2020;106(19):1503–11.
Mutambudzi M, Niedwiedz C, Macdonald EB, et al. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med 2020;78(5):307–14.

How to Treat

Prostate cancer consultations are common in primary care and there is no one approach to testing and treatment that fits all patients. Urologist Simon van Rij discusses the key considerations and options for personalised care, appropriate investigation and treatment

Wednesday 11 September 2024, 12:45 AM